Chromogranin peptides

Details Chromogranin peptides Chromogranin peptides

1995-06-16

1998-05-05

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530324, 530326, A61K 3800, C07K 500, C07K 700, C07K 1600

Patent

active

057474540

ABSTRACT:
This invention relates to synthetic chromogranin A peptides, pharmaceutical compositions comprising these peptides, and uses of the peptides for treating hyperparathyroidism, and treating or preventing conditions associated with hyperparathyroidism such as parathyroid hyperplasia-associated renal failure, osteoporosis, and the like.

REFERENCES:
patent: 5514775 (1996-05-01), Hogue-Angeletti et al.
Hogue-Angeletti, et al., Determination of Residues in Chromagranin A-(16-40) Required for Inhibition of Parathyroid Hormone Secretion, Endocrinology, 137(7), pp. 2918-2922, 1996.

Affiliated with

Also associated with

Rating

Chromogranin peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromogranin peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromogranin peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-54552